REG - Morgan Stanley Cap - Rule 38.5- ABBVIE INC.

Morgan StanleyAnnouncement

13/03/2020 11:30

RNS Number : 0940G
  
Morgan Stanley Capital Services LLC
  
13 March 2020
  
 

 
 FORM 38.5 
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)
 
DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS
 
1.             KEY INFORMATION



 Name of exempt market-maker


   Morgan Stanley Capital Services LLC




 Company dealt in


   ABBVIE INC.




 Class of relevant security to which the dealings being disclosed relate (Note 1)


  US$0.01 COMMON STOCK




 Date of dealing


   12 MARCH 2020



 
 
2.             DEALINGS (Note 2)
 
(a)           Purchases and sales



 Total number of relevant secuities accquired


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  56,968


 81.0300 USD


 77.3200 USD



 



 Total number of relevant secuities disposed


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  115,428


 85.3942 USD


 77.3200 USD



 
 
(b)           Derivatives transactions (other than options transactions)
 



 Product name, e.g. CFD


 Nature of transaction 
                (Note 4)


 Number of relevant securities 
                (Note 5)


 Price per unit




 CFD


 LONG


 300


 78.0200 USD




 CFD


 LONG


 585


 78.1734 USD




 CFD


 LONG


 1,070


 78.1734 USD




 CFD


 LONG


 2,657


 78.1734 USD




 CFD


 LONG


 4,064


 78.1734 USD




 CFD


 LONG


 9,718


 78.1734 USD




 CFD


 LONG


 6,154


 78.1734 USD




 CFD


 LONG


 39


 78.1900 USD




 CFD


 LONG


 3


 78.4500 USD




 CFD


 LONG


 780


 78.6100 USD




 CFD


 LONG


 456


 78.6100 USD




 CFD


 LONG


 4,100


 78.6100 USD




 CFD


 LONG


 21


 78.6785 USD




 CFD


 LONG


 108


 78.6789 USD




 CFD


 LONG


 900


 78.7322 USD




 CFD


 LONG


 300


 78.7322 USD




 CFD


 LONG


 400


 78.7322 USD




 CFD


 LONG


 500


 78.7322 USD




 CFD


 LONG


 12


 78.7900 USD




 CFD


 LONG


 16,927


 78.8268 USD




 CFD


 LONG


 393


 78.8268 USD




 CFD


 LONG


 695


 78.9626 USD




 CFD


 LONG


 5,100


 79.0187 USD




 CFD


 LONG


 3,800


 79.0381 USD




 CFD


 LONG


 1,174


 79.1150 USD




 CFD


 LONG


 5,528


 79.1150 USD




 CFD


 LONG


 1,187


 79.1260 USD




 CFD


 LONG


 39


 79.5351 USD




 CFD


 SHORT


 13


 78.4276 USD




 CFD


 SHORT


 1,450


 78.6547 USD




 CFD


 SHORT


 624


 78.6720 USD




 CFD


 SHORT


 7,184


 78.6899 USD




 CFD


 SHORT


 5,180


 78.7287 USD




 CFD


 SHORT


 4,348


 79.0595 USD




 CFD


 SHORT


 8,000


 79.4958 USD



 
 
(c)            Options transactions in respect of existing relevant securities
 
i)           Writing, selling, purchasing or varying
 



 Product name, eg call option


 Writing, selling, purchasing, varying etc


 Number of securities to which the option relates (Note 5)


 Exercise Price


 Type, e.g American, European etc 


 Expiry Date 


 Option money paid/received per unit (Note 3)




 N/A


 N/A


 N/A


 N/A


 N/A


 N/A


 N/A 



 
(ii) Exercising
 



 Product name, eg call option


 Number of securities


 Exercise price per unit (Note 3)




 N/A


 N/A


 N/A  



 
 
3. OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 



Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 




 
 
 
 
 



 
 



 Date of disclosure


 13 MARCH 2020




 Contact Name


Craig Horsley




 Telephone Number


+44(141) 245 7736 




 Name of offeree/offeror with which connected


ABBVIE INC. 




Nature of connection (Note 6)


Advisory 



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ISEJJMMTMTTBBPM